Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA

FEBS Letters

Volumn 586, Issue 19, 2012, Pages 3215-3221

  Zhang, Xuan ^a   You, Xiaona ^a   Li, Nan ^a   Zhang, Weiying ^a   Gagos, Sarantis ^b   Wang, Qi ^a   Banos, Aggelos ^b   Cai, Na ^a   Zhang, Huakun ^c   Zhang, Hang ^a   Zhang, Xuezhi ^a   Shan, Changliang ^a   Qiu, Liyan ^a   Zhang, Shuai ^a   Lv, Na ^a   Chen, Minshan ^c   Du, Yumei ^a   Xia, Jianchuan ^c   Ye, Lihong ^d   Zhang, Xiaodong ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d NANKAI UNIVERSITY   (China)

Author keywords

HBx; Hepatocarcinogenesis; Integration; Recombination; Subtelomeric

Indexed keywords

HEPATITIS B VIRUS X PROTEIN;

ADULT; AGED; ALU SEQUENCE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA INTEGRATION; DNA RECOMBINATION; FEMALE; HBX GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TELOMERE; VIRUS GENE;

ALU ELEMENTS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TRANSFORMED; DNA, NEOPLASM; DNA, VIRAL; GENES, VIRAL; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; TELOMERE; TRANS-ACTIVATORS; VIRUS INTEGRATION;

HEPATITIS B VIRUS;

EID: 84866621296     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.06.039     Document Type: Article

References (30)

1. M.A. Feitelson, B. Sun, N.L. Satiroglu Tufan, J. Liu, J. Pan, and Z. Lian Genetic mechanisms of hepatocarcinogenesis Oncogene 21 2002 2593 2604
2. Y. Tanaka The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1 Oncogene 25 2006 633 642
3. G.G. Chen, M.Y. Li, R.L. Ho, E.C. Chak, W.Y. Lau, and P.B. Lai Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma J. Med. Virol. 34 2005 7 12
4. Q. Wang, W. Zhang, Q. Liu, X. Zhang, N. Lv, and L. Ye A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase Neoplasia 12 2010 103 115
5. H. Zhu, Y. Wang, J. Chen, G. Cheng, and J. Xue Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis Exp. Mol. Pathol. 76 2004 44 50
6. Y. Wang, S.H. Lau, J.S. Sham, M.C. Wu, T. Wang, and X.Y. Guan Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis Oncogene 23 2004 142 148
7. D. Cougot, C. Neuveut, and M.A. Buendia HBV induced carcinogenesis J. Clin. Virol. 34 Suppl. 1 2005 S75 S78
8. Y. Murakami, K. Saigo, H. Takashima, M. Minami, T. Okanoue, C. Brechot, and P. Paterlini-Brechot Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas Gut 54 2005 1162 1168
9. A. Tamori Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus Am. J. Gastroenterol. 100 2005 1748 1753
10. W.Y. Zhang, N. Cai, L.H. Ye, and X.D. Zhang Transformation of human liver L-O2 cells mediated by stable HBx transfection Acta Pharmacol. Sin. 30 2009 1153 1161
11. G.Y. Hwang, C.Y. Lin, L.M. Huang, Y.H. Wang, J.C. Wang, C.T. Hsu, S.S. Yang, and C.C. Wu Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma J. Clin. Microbiol. 41 2003 5598 5603
12. N.H. Tang, Y.L. Chen, X.Q. Wang, X.J. Li, F.Z. Yin, and X.Z. Wang Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier World J. Gastroenterol. 9 2003 79 83
13. F.Z. Wang, L. Sha, W.Y. Zhang, L.Y. Wu, L. Qiao, N. Li, X.D. Zhang, and L.H. Ye Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells Acta Pharmacol. Sin. 28 2007 431 438
14. H. Zhang Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation Acta Pharmacol. Sin. 29 2008 473 480
15. X. Zhang, N. Dong, H. Zhang, J. You, H. Wang, and L. Ye Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells J. Lab. Clin. Med. 145 2005 98 104
16. X.M. Xin, G.Q. Li, X.R. Guan, D. Li, W.Z. Xu, Y.Y. Jin, and H.X. Gu Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell Hepatogastroenterology 55 2008 2178 2183
17. S. Kawai, O. Yokosuka, F. Imazeki, Y. Maru, and H. Saisho State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR J. Med. Virol. 64 2001 410 418
18. A. Tamori Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA Clin. Cancer Res. 11 2005 5821 5826
19. M.J. Ferber Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers Oncogene 22 2003 3813 3820
20. P. Paterlini-Brechot, K. Saigo, Y. Murakami, M. Chami, D. Gozuacik, C. Mugnier, D. Lagorce, and C. Brechot Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene Oncogene 22 2003 3911 3916
21. B. Sun, and M. Karin NF-kappaB signaling, liver disease and hepatoprotective agents Oncogene 27 2008 6228 6244
22. F.X. Bosch, J. Ribes, M. Diaz, and R. Cleries Primary liver cancer: worldwide incidence and trends Gastroenterology 127 2004 S5 S16
23. E. Shaulian, and M. Karin AP-1 in cell proliferation and survival Oncogene 20 2001 2390 2400
24. N.S. Rudiger, N. Gregersen, and M.C. Kielland-Brandt One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi Nucleic Acids Res. 23 1995 256 260
25. S.Y. Hsieh, S.F. Liaw, S.N. Lee, P.S. Hsieh, K.H. Lin, C.M. Chu, and Y.F. Liaw Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells Br. J. Cancer 88 2003 210 216
26. E.V. Linardopoulou, E.M. Williams, Y. Fan, C. Friedman, J.M. Young, and B.J. Trask Human subtelomeres are hot spots of interchromosomal recombination and segmental duplication Nature 437 2005 94 100
27. P.G. van Overveld, R.J. Lemmers, G. Deidda, L. Sandkuijl, G.W. Padberg, R.R. Frants, and S.M. van der Maarel Interchromosomal repeat array interactions between chromosomes 4 and 10: a model for subtelomeric plasticity Hum. Mol. Genet. 9 2000 2879 2884
28. E. Baker Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies Am. J. Med. Genet. 107 2002 285 293
29. Y.C. Kim, K.S. Song, G. Yoon, M.J. Nam, and W.S. Ryu Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis Oncogene 20 2001 16 23
30. H. Tu, H.F. Gao, G.H. Ma, and Y. Liu Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B Zhonghua Yi Xue Za Zhi 86 2006 1249 1252